Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer

dc.contributor.authorPapadopoulou, E.en
dc.contributor.authorDavilas, E.en
dc.contributor.authorSotiriou, V.en
dc.contributor.authorGeorgakopoulos, E.en
dc.contributor.authorGeorgakopoulou, S.en
dc.contributor.authorKoliopanos, A.en
dc.contributor.authorAggelakis, F.en
dc.contributor.authorDardoufas, K.en
dc.contributor.authorAgnanti, N. J.en
dc.contributor.authorKarydas, I.en
dc.contributor.authorNasioulas, G.en
dc.date.accessioned2015-11-24T19:31:18Z
dc.date.available2015-11-24T19:31:18Z
dc.identifier.issn0077-8923-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23243
dc.rightsDefault Licence-
dc.subjectAntigens, Surface/blood/geneticsen
dc.subject*Breast Neoplasms/blood/diagnosis/geneticsen
dc.subjectCarcinoembryonic Antigen/blood/geneticsen
dc.subjectCell Cycle Proteins/blood/geneticsen
dc.subjectDNA/*blooden
dc.subjectDNA Methylationen
dc.subjectDNA-Binding Proteins/blood/geneticsen
dc.subjectFemaleen
dc.subjectGenetic Markersen
dc.subjectGlutamate Carboxypeptidase II/blood/geneticsen
dc.subjectGlutathione S-Transferase pi/blood/geneticsen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectPlasma/*chemistryen
dc.subjectPromoter Regions, Geneticen
dc.subject*Prostatic Neoplasms/blood/diagnosis/geneticsen
dc.subjectProtein-Serine-Threonine Kinases/blood/geneticsen
dc.subjectRNA/*blooden
dc.subject*Tumor Markers, Biologicalen
dc.subjectTumor Suppressor Proteins/blood/geneticsen
dc.titleCell-free DNA and RNA in plasma as a new molecular marker for prostate and breast canceren
heal.abstractIn this study, we examined several molecular markers in prostate and breast cancer patients and in normal individuals. The markers tested were: variations in the quantity of plasma DNA, glutathione-S-transferase P1 gene (GSTP1), Ras association domain family 1A (RASSF1A), and ataxia telangiectasia mutated (ATM) methylation status in plasma, carcinoembryonic antigen (CEA) and prostate-specific membrane antigen (PSMA) mRNA in peripheral blood mononuclear cells (PBMC) and plasma samples from prostate cancer patients. DNA quantification in plasma was performed using real-time PCR (RT-PCR). We assessed the methylation status of GSTP1 in plasma DNA using methylation-specific PCR (MSP) assay, while the methylation status of RASSF1A and ATM genes was examined by the MethyLight technology. RT-PCR analysis was used for the detection of mRNA, PSMA, and CEA. In 58.3% of newly diagnosed prostate cancer patients and 26.7% of prostate cancer patients under therapy, plasma DNA levels were increased. Additionally, 48.5% of breast cancer patients showed plasma DNA levels above the cutoff limit. GSTP1 Promotor hypermethylation was detectable in 75% of plasma samples obtained from patients with newly diagnosed prostate cancer and in 36.8% of patients under therapy, whereas 26% and 14% of the breast cancer patients tested were positive for RASSF1A and ATM methylation, respectively. The combination of DNA load and promotor methylation status identified 88% of prostate cancer patients and 54% of breast cancer patients. This study shows that free-circulating DNA can be detected in cancer patients compared with disease-free individuals, and suggests a new, noninvasive approach for early detection of cancer.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1196/annals.1368.032-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17108217-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1196/annals.1368.032/asset/annals.1368.032.pdf?v=1&t=h1sz13hz&s=6096b5bb41fe7a85a2e431061e077ad6968197f7-
heal.journalNameAnn N Y Acad Scien
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: